Microbot Medical (NASDAQ:MBOT) Posts Earnings Results, Beats Expectations By $0.07 EPS

Microbot Medical (NASDAQ:MBOT) announced its quarterly earnings results on Wednesday. The biotechnology company reported ($0.08) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.07, Zacks reports.

Microbot Medical Stock Performance

Microbot Medical stock opened at $2.54 on Thursday. The company has a market capitalization of $92.40 million, a PE ratio of -3.17 and a beta of 1.15. The firm has a 50 day moving average price of $2.10 and a 200 day moving average price of $1.67. Microbot Medical has a fifty-two week low of $0.82 and a fifty-two week high of $3.38.

Institutional Investors Weigh In On Microbot Medical

An institutional investor recently bought a new position in Microbot Medical stock. Goldman Sachs Group Inc. bought a new position in shares of Microbot Medical Inc. (NASDAQ:MBOT) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 37,744 shares of the biotechnology company’s stock, valued at approximately $57,000. Goldman Sachs Group Inc. owned 0.11% of Microbot Medical at the end of the most recent quarter. 16.30% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, HC Wainwright reiterated a “buy” rating and issued a $9.00 target price on shares of Microbot Medical in a report on Thursday, April 10th.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.